Lupin shares decline after USFDA issues six observations for Nagpur facility

Lupin said the US Food and Drug Administration (USFDA) conducted an inspection at the facility between September 8 to September 16 and that the company will address the observations within the stipulated timeframe.

Leave a Reply

Your email address will not be published. Required fields are marked *